Ambrx Biopharma, Inc. (AMAM)
AMAM has a market cap or net worth of $148.57 million. The enterprise value is -$9.21 million.
AMAM has 38.59 million shares outstanding.
|Shares Change (YoY)||n/a|
|Shares Change (QoQ)||n/a|
|Owned by Insiders (%)||n/a|
|Owned by Institutions (%)||51.08%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 7.19, with a Debt / Equity ratio of 0.07.
|Debt / Equity||0.07|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -269.40%, which is considered low. The company has a ROIC of -2,080.00%.
|Return on Equity (ROE)||-269.40%|
|Return on Assets (ROA)||-37.50%|
|Return on Capital (ROIC)||-2,080.00%|
|Revenue Per Employee||$92,037|
|Profits Per Employee||-$840,481|
In the past 12 months, AMAM has paid $1,000 in taxes.
|Effective Tax Rate||n/a|
Stock Price Statistics
|Total Price Change||-78.61%|
|50-Day Moving Average||3.97|
|200-Day Moving Average||6.37|
|Average Volume (30 Days)||6,958|
Short Selling Information
The latest short interest is 5,598, so 0.01% of the outstanding shares have been sold short.
|Short % of Shares Out||0.01%|
|Short % of Float||0.04%|
|Short Ratio (days to cover)||0.60|
In the last 12 months, AMAM had revenue of $7.46 million and -68.08 million in losses. Earnings per share was -$3.33.
|Earnings Per Share (EPS)||-$3.33|
The company has $170.91 million in cash and $13.13 million in debt, giving a net cash position of $157.78 million or $4.09 per share.
|Cash & Cash Equivalents||170.91M|
|Net Cash Per Share||$4.09|
|Book Value Per Share||4.92|
In the last 12 months, operating cash flow was -$44.64 million and capital expenditures -$1.96 million, giving a free cash flow of -$46.60 million.
|Operating Cash Flow||-44.64M|
|Free Cash Flow||-46.60M|
|FCF Per Share||n/a|
Gross margin is 100.00%, with operating and profit margins of -864.17% and -913.20%.
Dividends & Yields
AMAM does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for AMAM is $14.62, which is 279.74% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||279.74%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|